Dual markets structures and the likelihood of repeated ties - evidence from pharmaceutical biotechnology
AbstractNo abstract is available for this item.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by Maastricht University in its series Open Access publications from Maastricht University with number urn:nbn:nl:ui:27-5881.
Date of creation: 2005
Date of revision:
Publication status: Published in Research policy : a journal devoted to research policy, research management and planning (2005) v.34, p.235-245
Contact details of provider:
Web page: http://www.maastrichtuniversity.nl/web/Home.htm
You can help add them by filling out this form.
CitEc Project, subscribe to its RSS feed for this item.
- Krogmann, Yin & Riedel, Nadine & Schwalbe, Ulrich, 2013. "Inter-firm R&D networks in pharmaceutical biotechnology: What determines firm's centrality-based partnering capability," FZID Discussion Papers 75-2013, University of Hohenheim, Center for Research on Innovation and Services (FZID).
- Gilsing, Victor & Nooteboom, Bart, 2006. "Exploration and exploitation in innovation systems: The case of pharmaceutical biotechnology," Research Policy, Elsevier, vol. 35(1), pages 1-23, February.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (J.Odekerken).
If references are entirely missing, you can add them using this form.